Treatment of osteoarthritis with autologous, micro-fragmented adipose tissue: a study protocol for a randomized controlled trial
Open Access
- 27 October 2021
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-11
Abstract
Background: Osteoarthritis is a destructive joint disease that leads to degeneration of cartilage and other morphological changes in the joint. No medical treatment currently exists that can reverse these morphological changes. Intra-articular injection with autologous, micro-fragmented adipose tissue has been suggested to relieve symptoms. Methods/Design: The study is a blinded randomized controlled trial with patients allocated in a 1:1 ratio to 2 parallel groups. Patients suffering from pain and functional impairment due to osteoarthritis Kellgren-Lawrence grades 2–3 in the tibiofemoral joint are eligible for inclusion. The intervention group is treated with an intra-articular injection with autologous, micro-fragmented adipose tissue prepared using the Lipogems® system. The control group receives an intra-articular injection with isotonic saline. In total, 120 patients are to be included. The primary outcome is The Knee injury and Osteoarthritis Outcome Score (KOOS4) evaluated at 6 months. Secondary outcomes are KOOS at 3, 12 and 24 months; the Tegner activity score; treatment failure; and work status of the patient. The analysis will be conducted both as intention-to-treat and per-protocol analysis. Discussion: This trial is the first to investigate the efficacy of autologous, micro-fragmented adipose tissue in a randomized controlled trial. The study uses the patient-reported outcome measure Knee Injury and Osteoarthritis Outcome Score (KOOS4) after 6 months as the primary outcome, as it is believed to be a valid measure to assess the patient’s opinion about their knee and associated problems when suffering from osteoarthritis.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- The MSC: An Injury DrugstoreCell Stem Cell, 2011
- Osteoarthritis year 2010 in review: non-pharmacologic therapyOsteoarthritis and Cartilage, 2011
- Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 monthsJournal of Tissue Engineering and Regenerative Medicine, 2011
- A Randomized Trial of Treatment for Acute Anterior Cruciate Ligament TearsNew England Journal of Medicine, 2010
- Articular cartilage and subchondral bone in the pathogenesis of osteoarthritisAnnals of the New York Academy of Sciences, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Knee Injury and Osteoarthritis Outcome Score (KOOS)Journal of Orthopaedic Trauma, 2006
- Fixation of Periprosthetic Femoral Shaft Fractures Associated With Cemented Femoral StemsJournal of Orthopaedic Trauma, 2006
- The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this conditionRheumatology, 2005
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999